Pregnancy-induced changes in cell-fate in the mammary gland

Breast Cancer Research

Volumn 5, Issue 4, 2003, Pages 192-197

  Ginger, Melanie R ^a   Rosen, Jeffrey M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; Cell fate; Epigenetic; Mechanism; Pregnancy; Protection

Indexed keywords

ACID PROTEIN; AMPHIREGULIN; BETA GALACTOSIDASE; CRE RECOMBINASE; DNA; ESTRADIOL BENZOATE; ESTROGEN; GROWTH FACTOR; LEPTIN; METHYLNITROSOUREA; PLEIOTROPHIN; PROGESTERONE; PROTEIN P53; RNA; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA3;

APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CELL; BREAST EPITHELIUM; CANCER RESISTANCE; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL PROLIFERATION; CELL PROTECTION; CELL SPECIFICITY; CELL SURVIVAL; EPITHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; GROWTH REGULATION; HEMATOPOIETIC CELL; MAMMARY GLAND FUNCTION; MOLECULAR MECHANICS; NONHUMAN; NORTHERN BLOTTING; PARITY; PREGNANCY; SIGNAL TRANSDUCTION;

ANIMALS; FEMALE; GENE EXPRESSION; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; PARITY; PREGNANCY; PREGNANCY COMPLICATIONS; RATS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0038386699     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr603     Document Type: Article

References (25)

1. Chodosh LA, D'Cruz CM, Gardner HP, Ha SI, Marquis ST, Rajan JV, Stairs DB, Wang JY, Wang M: Mammary gland development, reproductive history, and breast cancer risk. Cancer Res 1999, 59(suppl):1765s-1771s; discussion 1771s-1772s.
2. Kelsey JL, Gammon MD: The epidemiology of breast cancer. CA Cancer J Clin 1991, 41:146-165.
3. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S: Age at first birth and breast cancer risk. Bull World Health Organ 1970, 43:209-221.
4. Rosner B, Colditz GA, Willett WC: Reproductive risk factors in a prospective study of breast cancer: the Nurses' Health Study. Am J Epidemiol 1994, 139:819-835.
5. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG: 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature 1983, 303:767-770.
6. Sivaraman L, Medina D: Hormone-induced protection against breast cancer. J Mammary Gland Biol Neoplasia 2002, 7:77-92.
7. Russo IH, Koszalka M, Russo J: Human chorionic gonadotropin and rat mammary cancer prevention. J Natl Cancer Inst 1990, 82:1286-1289.
8. Russo IH, Koszalka M, Russo J: Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis. Carcinogenesis 1990, 11:1849-1855.
9. Sivaraman L, Stephens LC, Markaverich BM, Clark JA, Krnacik S, Conneely OM, O'Malley BW, Medina D: Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats. Carcinogenesis 1998, 19:1573-1581.
10. Thordarson G, Jin E, Guzman RC, Swanson SM, Nandi S, Talamantes F: Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia? Carcinogenesis 1995, 16:2847-2853.
11. Grubbs CJ, Farnell DR, Hill DL, McDonough KC: Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17 beta-estradiol and progesterone. J Natl Cancer Inst 1985, 74:927-931.
12. Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X, Nandi S: Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci USA 1999, 96: 2520-2525.
13. Huggins C, Moon JRC, Morii S: Extinction of experimental mammary cancer, I. Estradiol-17b and progesterone. Proc Natl Acad Sci USA 1962, 48:379-386.
14. Ginger MR, Gonzalez-Rimbau MF, Gay JP, Rosen JM: Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. Mol Endocrinol 2001, 15: 1993-2009.
15. D'Cruz CM, Moody SE, Master SR, Hartman JL, Keiper EA, Imielinski MB, Cox JD, Wang JY, Ha SI, Keister BA, Chodosh LA: Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Mol Endocrinol 2002, 16:2034-2051.
16. Medina D, Smith GH: Chemical carcinogen-induced tumorigenesis in parous, involuted mouse mammary glands. J Natl Cancer Inst 1999, 91:967-969.
17. Sivaraman L, Conneely OM, Medina D, O'Malley BW: p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis. Proc Natl Acad Sci USA 2001, 98:12379-12384.
18. Faure E, Heisterkamp N, Groffen J, Kaartinen V: Differential expression of TGF-beta isoforms during postlactational mammary gland involution. Cell Tissue Res 2000, 300:89-95.
19. Minter LM, Dickinson ES, Naber SP, Jerry DJ: Epithelial cell cycling predicts p53 responsiveness to gamma-irradiation during post-natal mammary gland development. Development 2002, 129:2997-3008.
20. Wagner KU, Boulanger CA, Henry MD, Sgagias M, Hennighausen L, Smith GH: An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. Development 2002, 129:1377-1386.
21. Bemis LT, Schedin P: Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. Cancer Res 2000, 60:3414-3418.
22. Muller C, Leutz A: Chromatin remodeling in development and differentiation. Curr Opin Genet Dev 2001, 11:167-174.
23. Wolffe AP, Urnov FD, Guschin D: Co-repressor complexes and remodelling chromatin for repression. Biochem Soc Trans 2000, 28:379-386.
24. Dernburg AF, Karpen GH: A chromosome RNAissance. Cell 2002, 111:159-162.
25. Mattick JS: Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep 2001, 2:986-991.